Found 75 results
Author [ Keyword(Asc)] Title Type Year
Filters: Author is Muchiri, Ruth N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Limit of Detection
Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.  2018.  Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 32(22):1941-1948.
Ligands
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Hypoxia
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Humans
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
van Breemen RB, Muchiri RN.  2024.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.. Mass Spectrom Rev. 43(1):39-46.
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Irawan A, Muchiri RN, Parker NB, van Breemen RB, Ates S, Bionaz M.  2024.  Cannabinoid residuals in tissues of lambs fed spent hemp biomass and consumer's exposure assessment.. Food Chem Toxicol. 191:114848.
High-Throughput Screening Assays
Muchiri RN, van Breemen RB.  2021.  Drug discovery from natural products using affinity selection-mass spectrometry.. Drug Discov Today Technol. 40:59-63.
Food Contamination
Irawan A, Muchiri RN, Parker NB, van Breemen RB, Ates S, Bionaz M.  2024.  Cannabinoid residuals in tissues of lambs fed spent hemp biomass and consumer's exposure assessment.. Food Chem Toxicol. 191:114848.
Fabaceae
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Ethiodized Oil
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Esters
Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.  2018.  Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 32(22):1941-1948.
Emulsions
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Drug Evaluation, Preclinical
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Drug Discovery
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Muchiri RN, van Breemen RB.  2021.  Drug discovery from natural products using affinity selection-mass spectrometry.. Drug Discov Today Technol. 40:59-63.
Dronabinol
Irawan A, Muchiri RN, Parker NB, van Breemen RB, Ates S, Bionaz M.  2024.  Cannabinoid residuals in tissues of lambs fed spent hemp biomass and consumer's exposure assessment.. Food Chem Toxicol. 191:114848.
Doxorubicin
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
COVID-19 Drug Treatment
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
COVID-19
van Breemen RB, Muchiri RN.  2024.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.. Mass Spectrom Rev. 43(1):39-46.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Chromatography, High Pressure Liquid
Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.  2018.  Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 32(22):1941-1948.

Pages